Reporting in the journal Nature, researchers write that ZMapp—the cocktail of antibodies used to treat two American aid workers infected with the Ebola virus—spared 18 severely ill monkeys from death. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, weighs in on the new results and whether they can be expected to hold up in humans.